Wargacki Stephen 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Wargacki Stephen
Chief Science Officer
Transactions
- Tax Payment
Common Stock
[F1]2024-03-09$4.88/sh−11,269$54,993→ 259,650 total - Tax Payment
Common Stock
[F1]2024-03-10$4.88/sh−1,687$8,233→ 257,963 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.
Signature
/s/ Lori Braender, as Attorney-In-Fact|2024-03-12